Retrieve available abstracts of 206 articles: HTML format
Single Articles
July 2025
KAPLAN I, Komek H, Can C, Kaya Ipek F, et al Effect of body composition parameters, including sarcopenia, myosteatosis, and
adipose tissue, on overall survival of patients with mCRPC receiving 177 Lu-PSMA
PRRT.
Nucl Med Commun. 2025;46:592-598. PubMedAbstract available
SINGHAL T, Singh P, Parida GK, Agrawal K, et al Leg-muscle perfusion reserve on 99mTc-MIBI stress-rest scintigraphy: the novel
use of radionuclide imaging in assessing lower extremity functional capacity.
Nucl Med Commun. 2025;46:599-604. PubMedAbstract available
June 2025
MOHLAPHOLI MS, Doruyter A, Mix M, Trauernicht C, et al The use of simulations to study the effect of acquisition schemes and
quantification methods using positron emission tomography: an 18F-Fallypride
study.
Nucl Med Commun. 2025 Jun 6. doi: 10.1097/MNM.0000000000001995. PubMedAbstract available
WANG Y, Yang G, Yan W, Yu W, et al 18 F-FAPI PET/CT in chronic liver disease: myocardial fibroblast activation and
its correlates.
Nucl Med Commun. 2025 Jun 5. doi: 10.1097/MNM.0000000000002002. PubMedAbstract available
LEITE E SILVA MH, Barbosa da Silva MA, Dos Santos DSR, Fagundes TC, et al PET for predicting chemoradiotherapy survival in cervical cancer: the search
continues.
Nucl Med Commun. 2025 Jun 5. doi: 10.1097/MNM.0000000000001999. PubMedAbstract available
MUTEVELIZADE G, Aydin N, Duran Can O, Teke O, et al Predicting clinical outcomes using 18F-FDG PET/CT-based radiomic features and
machine learning algorithms in patients with esophageal cancer.
Nucl Med Commun. 2025 Jun 4. doi: 10.1097/MNM.0000000000002003. PubMedAbstract available
DESOUZA K, Fessas P, Spurrell E, Papadimitraki E, et al The safety and clinical impact of ultra-low-dose FDG-PET imaging in
pregnancy-associated breast cancer: the experience of a major tertiary oncology
referral centre in the UK and suggested imaging protocol.
Nucl Med Commun. 2025 Jun 4. doi: 10.1097/MNM.0000000000001997. PubMedAbstract available
WANG J, Liu B, Zhang F, Wang J, et al The prognostic value of left ventricular diastolic dyssynchrony combined with
myocardial perfusion, systolic dyssynchrony, and cardiovascular risk factors in
patients with normal left ventricular ejection fraction.
Nucl Med Commun. 2025;46:545-552. PubMedAbstract available
May 2025
WANG QC, Cheng MH, Xie LJ Semiquantitative analysis of 18F-aluminum fluoride fibroblast activation protein
inhibitor 42 PET/computed tomography in primary liver cancer and factors
influencing imaging positivity rates.
Nucl Med Commun. 2025 May 20. doi: 10.1097/MNM.0000000000001994. PubMedAbstract available
JUNG KJ, Hong SP, Yoo ID, Lee SM, et al Association of quantitative growth plate uptake parameters on bone scintigraphy
with growth velocity in children.
Nucl Med Commun. 2025 May 19. doi: 10.1097/MNM.0000000000001992. PubMedAbstract available
WANG Y, Hou M, Zuo T Advances in the application of 18F-sodium fluoride PET in the assessment of
atherosclerosis.
Nucl Med Commun. 2025 May 8. doi: 10.1097/MNM.0000000000001988. PubMedAbstract available
ABDLKADIR AS, Al-Adhami D, Al Rammahi M, Badarneh M, et al Diagnostic pitfalls in [68Ga]Ga-DOTATATE PET/CT imaging: a systematic review.
Nucl Med Commun. 2025 May 6. doi: 10.1097/MNM.0000000000001987. PubMedAbstract available
ALMASLAMANI M, Byun BH, Song K, Kong CB, et al PET image nonuniformity texture features for metastasis risk prediction in
osteosarcoma.
Nucl Med Commun. 2025 May 6. doi: 10.1097/MNM.0000000000001989. PubMedAbstract available
ZHANG H, Pang L, Hou J, Li B, et al Significance of 18F-fluorodeoxyglucose PET/computed tomography in the initial
staging of malignant peritoneal mesothelioma.
Nucl Med Commun. 2025 May 6. doi: 10.1097/MNM.0000000000001990. PubMedAbstract available
LENAERTS M, van Amstel FJG, Mottaghy FM, Geurts SME, et al A review of the association between baseline [ 18 F] fluorodeoxyglucose uptake
and axillary pathological complete response in node-positive breast cancer
patients: focus on clinical subtypes.
Nucl Med Commun. 2025;46:384-391. PubMedAbstract available
British Nuclear Medicine Society Spring Meeting 19th-21st May 2025.
Nucl Med Commun. 2025;46:453-501. PubMed
CHEN HY, Tsai YJ, Peng SJ Interpretation of basal nuclei in brain dopamine transporter scans using a deep
convolutional neural network.
Nucl Med Commun. 2025;46:418-426. PubMedAbstract available
AMINDAROLZARBI A, Satcowitz K, Khalil A, Osman S, et al Lack of effect of renal function on uptake of 99m Tc-sestamibi in renal masses.
Nucl Med Commun. 2025;46:392-395. PubMedAbstract available
BONGA KN, Agrawal K, Tripathy SK, Meher BR, et al Effectiveness and safety of radionuclide synovectomy with Yttrium-90
hydroxyapatite in patients with inflammatory arthritis: a longitudinal study.
Nucl Med Commun. 2025;46:396-403. PubMedAbstract available
April 2025
NISHIMORI M, Iwasa H, Miyatake K, Nitta N, et al Correlation between PD-L1 expression and FDG-PET/CT visual assessments in
non-small cell lung cancer resected specimens.
Nucl Med Commun. 2025 Apr 29. doi: 10.1097/MNM.0000000000001984. PubMedAbstract available
SAHIN AM, Sen E, Ozkan E, Dursun E, et al Thoracic metabolic tumor volume predicts survival in advanced lung
adenocarcinoma: a PET/computed tomography-based cohort study.
Nucl Med Commun. 2025 Apr 23. doi: 10.1097/MNM.0000000000001983. PubMedAbstract available
ABDLKADIR AS, Allouzi S, Obeidat S, Mikhail-Lette M, et al Exploring utilities of [ 64 Cu]Cu-DOTA-trastuzumab immunoPET in breast cancer: a
systematic review and meta-analysis.
Nucl Med Commun. 2025;46:277-284. PubMedAbstract available
CALANDRI E, Verdoia M, Sirovich R, Giraudo MT, et al Combined single-photon emission computed tomography-myocardial perfusion imaging
with coronary calcium score for assessing coronary disease.
Nucl Med Commun. 2025;46:317-325. PubMedAbstract available
March 2025
RIZWAN S, Ayubcha C, Al-Daoud O, Al-Atout M, et al PET imaging of atherosclerosis: artificial intelligence applications and recent
advancements.
Nucl Med Commun. 2025 Mar 27. doi: 10.1097/MNM.0000000000001973. PubMedAbstract available
USMANI S, Al Riyami K, Ahmed N, Burney IA, et al The role of 68Ga-FAPI PET/CT imaging in gynecological cancers: an integrative
review.
Nucl Med Commun. 2025 Mar 25. doi: 10.1097/MNM.0000000000001977. PubMedAbstract available
CHEN X, Qi H, Zou Y, Chen Y, et al Predicting the spread through air spaces in lung adenocarcinoma from preoperative
18F-FDG PET/CT radiomics.
Nucl Med Commun. 2025 Mar 18. doi: 10.1097/MNM.0000000000001975. PubMedAbstract available
PENG M, Yang X, Wang Y, Zhou L, et al Clinical combined PET/CT radiomics model prediction of benefit from
platinum-based chemotherapy and chemoradiotherapy in patients with small cell
lung cancer.
Nucl Med Commun. 2025 Mar 14. doi: 10.1097/MNM.0000000000001971. PubMedAbstract available
ZHANG R, Zhang X, Gao Q, Zhang H, et al Prognostic significance of total metabolic tumor volume on baseline 18F-FDG
PET/CT in patients with lung adenocarcinoma: further stratification of the ninth
edition of TNM staging subgroups.
Nucl Med Commun. 2025 Mar 14. doi: 10.1097/MNM.0000000000001976. PubMedAbstract available
BROWN S, Kwok F, Evans S, Geenty P, et al 99mTechnetium-pyrophosphate SPECT/CT with novel semiautomated quantification has
excellent diagnostic accuracy for detecting cardiac transthyretin amyloidosis.
Nucl Med Commun. 2025 Mar 12. doi: 10.1097/MNM.0000000000001972. PubMedAbstract available
STROBEL K, Grunig H, Lima T, Bartschi D, et al Comparison of reprojected 'pseudoplanar' bone SPECT/CT and planar bone
scintigraphy for the detection and localization of foot and ankle osteoarthritis.
Nucl Med Commun. 2025 Mar 12. doi: 10.1097/MNM.0000000000001974. PubMedAbstract available
KIMOTO H, Owaki Y, Minamishima K, Inoue K, et al Optimization of imaging conditions for technetium-99m dimercaptosuccinic acid
single photon emission computed tomography examinations in neonates.
Nucl Med Commun. 2025 Mar 3. doi: 10.1097/MNM.0000000000001962. PubMedAbstract available
TOYAMA T, Kasama S, Sato M, Sano H, et al The most important prognostic factors for predicting major adverse
cardiovascular, cerebrovascular, and renal events during 5-year follow-up of
patients with chronic kidney disease with or without haemodialysis.
Nucl Med Commun. 2025;46:223-229. PubMedAbstract available
SUBRAMANYAM P, Palaniswamy SS 18 F-FDG metabolic abnormalities precede perfusion and atrophic changes in
diagnosis of early frontotemporal dementia: study from a tertiary care university
hospital.
Nucl Med Commun. 2025;46:248-259. PubMedAbstract available
February 2025
GEMMELL AJ, Brown CM, Ray S, Small A, et al Comparison of quantitative Krenning Scores with visual assessment in
99mTc-EDDA/HYNIC-TOC SPECT-CT.
Nucl Med Commun. 2025 Feb 27. doi: 10.1097/MNM.0000000000001967. PubMedAbstract available
YAMAKUNI R, Ishii S, Fukushima K, Kakamu T, et al Comparison of visual interpretation of [I-123] FP-CIT SPECT scans versus
reference-based quantitative analysis utilizing a Japanese normal database.
Nucl Med Commun. 2025 Feb 25. doi: 10.1097/MNM.0000000000001968. PubMedAbstract available
KAPLAN I, Yeprem O, Komek H, Kepenek F, et al Contribution of tubarial salivary gland function detected through
68Ga-prostate-specific membrane antigen PET/computed tomography to total salivary
gland function.
Nucl Med Commun. 2025 Feb 25. doi: 10.1097/MNM.0000000000001970. PubMedAbstract available
GUO C, Luo J, Liang M, Xiao J, et al Correlation of 18F-FDG PET/CT metabolic parameters with Ki-67 expression and
tumor staging in nasopharyngeal carcinoma.
Nucl Med Commun. 2025 Feb 19. doi: 10.1097/MNM.0000000000001966. PubMedAbstract available
RUAN X, Zhang B, Chen Z, Wu H, et al Improved grading method of 99mTc-dimercaptosuccinic acid static renal imaging
helps predict the prognosis of urinary tract infection in children.
Nucl Med Commun. 2025 Feb 14. doi: 10.1097/MNM.0000000000001961. PubMedAbstract available
HUANG M, Wang Y, Yang X, Li N, et al Establishing a threshold for maximum standardized uptake value on
18F-fluorodeoxyglucose PET/CT to predict high-grade lung adenocarcinoma and its
prognostic significance.
Nucl Med Commun. 2025 Feb 12. doi: 10.1097/MNM.0000000000001959. PubMedAbstract available
FRASER L, Parkar N, Powell A, Richardson M, et al Interpretation and implementation of adult diagnostic reference levels in nuclear
medicine and positron emission tomography in the UK.
Nucl Med Commun. 2025 Feb 5. doi: 10.1097/MNM.0000000000001953. PubMedAbstract available
LI LL, Wang L, Li HW, Chen H, et al Utility of preoperative 18F-flurodeoxyglucose PET/CT scanning in preoperative
evaluation and surgical planning for pulmonary tuberculosis.
Nucl Med Commun. 2025;46:180-186. PubMedAbstract available
RICE SL, Munoz FG, Benjamin JL, Alnablsi MW, et al Local and systemic biodistribution of a small-molecule radiopharmaceutical probe
after transcatheter embolization and intra-arterial delivery in a porcine
orthotopic renal tumor model.
Nucl Med Commun. 2025;46:138-145. PubMedAbstract available
LU C, Yu Y, Wang S, Yin X, et al The application of extraocular muscle maximum standardized uptake value of
99mTc-diethylenetriamine pentaacetic acid orbital single photon emission computed
tomography/computed tomography in the assessment of Graves' orbitopathy.
Nucl Med Commun. 2025;46:120-127. PubMedAbstract available
ROSE DS, Hector BM, Kannan S, Lee JC, et al Sublingual glyceryl trinitrate given during adenosine sestamibi myocardial
perfusion imaging causes apparent transient ischaemic dilation in a
propensity-matched analysis.
Nucl Med Commun. 2025;46:128-137. PubMedAbstract available
January 2025
STEPIEN-WRONIECKA A, Dziewiecka E, Graczyk K, Holcman K, et al Gated myocardial perfusion SPECT for evaluating left ventricular dyssynchrony in
cardiac resynchronization therapy candidates: a systematic review.
Nucl Med Commun. 2025 Jan 24. doi: 10.1097/MNM.0000000000001955. PubMedAbstract available
SU S, Wang G, Ye X, Wang H, et al The role of 18F-FDG PET/CT in detecting recurrence and metastasis in
posttreatment nasopharyngeal carcinoma patients with elevated Epstein-Barr virus
DNA.
Nucl Med Commun. 2025 Jan 22. doi: 10.1097/MNM.0000000000001954. PubMedAbstract available
HU N, Yan G, Tang M, Yuan S, et al Prognostic value of serum cholinesterase and 18F-FDG PET/CT-derived metabolic
parameters in non-small cell lung cancer patients: a retrospective cohort study.
Nucl Med Commun. 2025 Jan 21. doi: 10.1097/MNM.0000000000001952. PubMedAbstract available
TING M, McDermott G, Zarei A, Patel C, et al Qualitative and quantitative analysis of reduced bed position acquisition time on
FDG PET image quality.
Nucl Med Commun. 2025 Jan 21. doi: 10.1097/MNM.0000000000001957. PubMedAbstract available
LI M, Liu J, Lv R, Liu F, et al Network topology and metabolic alterations in early- and mid-stage Parkinson's
disease: insights from fluorodeoxyglucose PET imaging.
Nucl Med Commun. 2025 Jan 20. doi: 10.1097/MNM.0000000000001951. PubMedAbstract available
FAN Y, Liu Y, Ouyang X, Su J, et al Prediction of EGFR mutation status and its subtypes in non-small cell lung cancer
based on 18F-FDG PET/CT radiological features.
Nucl Med Commun. 2025 Jan 20. doi: 10.1097/MNM.0000000000001948. PubMedAbstract available
ROMERO-FARINA G, Aguade-Bruix S, Ferreira-Gonzalez I Different degrees of summed difference perfusion score in women: influence on the
prognostic variables associated with cardiac events.
Nucl Med Commun. 2025;46:28-37. PubMedAbstract available
VILJAMAA HR, Ripatti LLM, Larjava HRS, Noponen TEJ, et al Radiation exposure in vesicoureteral reflux diagnostics: a comparative study of
direct radionuclide cystography and voiding cystourethrogram.
Nucl Med Commun. 2025;46:15-20. PubMedAbstract available
ZHANG M, Sun Y, Zhang L, Xu Y, et al The application of mass defect percentage in the evaluation of acute coronary
syndrome.
Nucl Med Commun. 2025;46:1-6. PubMedAbstract available
BURTON L, Khoma O, Gooley S, Falk GL, et al Solid versus liquid pulmonary micro-aspiration of reflux disease. Does it make a
difference in determining the need for intervention?
Nucl Med Commun. 2025;46:7-14. PubMedAbstract available
December 2024
TOYLI A, Hung GU, Zhao C, Sha Q, et al Comparison of cerebral technetium-99m-ethyl cysteinate dimer perfusion in
patients with dementia with Lewy bodies and Parkinson's disease dementia.
Nucl Med Commun. 2024 Dec 23. doi: 10.1097/MNM.0000000000001946. PubMedAbstract available
JAIN B, Khandelwal Y, Ora M, Mishra P, et al Metabolic markers derived from 18F-FDG PET/CT in suspected recurrent ovarian
carcinoma: predictive value for disease burden and prognosis.
Nucl Med Commun. 2024 Dec 17. doi: 10.1097/MNM.0000000000001944. PubMedAbstract available
SARIKAYA I Radionuclide treatments of cancer: molecular mechanisms, biological responses,
histopathological changes, and role of PET imaging.
Nucl Med Commun. 2024 Dec 10. doi: 10.1097/MNM.0000000000001941. PubMedAbstract available
CHEN Y, Zhang Q, Hu Y, Liu E, et al Semiquantitative muscle parameters derived from FAPI and FDG PET/CT in evaluating
sarcopenia among patients with malignant tumors.
Nucl Med Commun. 2024 Dec 9. doi: 10.1097/MNM.0000000000001945. PubMedAbstract available
PANDIT-TASKAR N, Basu E, Balquin E, Mozley PD, et al Safety observations in neuroblastoma patients undergoing 18F-mFBG PET.
Nucl Med Commun. 2024 Dec 6. doi: 10.1097/MNM.0000000000001938. PubMedAbstract available
ASKARI E, Saidi B, Evangelista L Indications for diagnostic whole-body iodine scan: a review of guidelines.
Nucl Med Commun. 2024;45:998-1006. PubMedAbstract available
ANTON FARIA R, Chagas Jaguar G, Nobrega Pereira Lima E Parametric imaging in salivary gland scintigraphy.
Nucl Med Commun. 2024;45:1098-1104. PubMedAbstract available
November 2024
OZKAN E, Unal S, Akkus P, Peker E, et al Diagnostic performance of fluorine-18-fluorodeoxyglucose PET/MRI for detection of
disease recurrence in differentiated thyroid cancer: a compartment-based
analysis.
Nucl Med Commun. 2024 Nov 28. doi: 10.1097/MNM.0000000000001937. PubMedAbstract available
YIN P, Maliha PG, Ebrahim A, Ben-Ezra N, et al Variants of physiological FDG vascular activity on digital PET.
Nucl Med Commun. 2024 Nov 28. doi: 10.1097/MNM.0000000000001935. PubMedAbstract available
LEE D, Green J, Crane J, Taylor DR, et al Adrenal oncocytoma: a rare presentation of a benign 18F-fluorodeoxyglucose PET
avid virilising adrenal tumour.
Nucl Med Commun. 2024 Nov 28. doi: 10.1097/MNM.0000000000001932. PubMedAbstract available
LUO Y, Li X, Sun J, Liu S, et al Predicting higher-risk growth patterns in invasive lung adenocarcinoma with
multiphase multidetector computed tomography and 18F-fluorodeoxyglucose PET
radiomics.
Nucl Med Commun. 2024 Nov 21. doi: 10.1097/MNM.0000000000001931. PubMedAbstract available
KESIM S, Turoglu HT, Kotan T, Balaban Genc ZC, et al Efficacy of additional lateral pinhole and SPECT/CT imaging in dual-phase Tc-99m
MIBI parathyroid scintigraphy for localising parathyroid pathologies in patients
with primary hyperparathyroidism: a single-institution experience.
Nucl Med Commun. 2024 Nov 8. doi: 10.1097/MNM.0000000000001924. PubMedAbstract available
WANG F, Chen Y, Tan X, Han X, et al PET/computed tomography radiomics combined with clinical features in predicting
sarcopenia and prognosis of diffuse large B-cell lymphoma.
Nucl Med Commun. 2024 Nov 5. doi: 10.1097/MNM.0000000000001925. PubMedAbstract available
TAKESHI N, Shota H, Tomoya K, Yasunori N, et al Image reconstruction parameters and the standardized uptake value ratios in brain
amyloid PET.
Nucl Med Commun. 2024;45:984-991. PubMedAbstract available
VOO S, Baldeweg SE, Kumar R, Singh H, et al Perennial inconsistencies and lack of evidence-based recommendations in current
guidelines addressing blood glucose level regulations for optimal
18F-fluorodeoxyglucose PET imaging: 25-year 'silver jubilee' of an ongoing
unsolved problem in nuclear me
Nucl Med Commun. 2024;45:897-900. PubMed
HASEGAWA D, Iguchi T, Takatani M, Tokunaga K, et al Effect of single-photon emission computed tomography acquisition method and
sampling angles on image quality and quantitative accuracy in
xSPECT-reconstructed images.
Nucl Med Commun. 2024;45:916-923. PubMedAbstract available
GRUNIG H, Strobel K, Zander A, Perez Lago MDS, et al Significance of incidental thyroid 18 F-fluorocholine uptake in patients with
hyperparathyroidism imaged for localizing hyperfunctioning parathyroid glands.
Nucl Med Commun. 2024;45:938-946. PubMedAbstract available
October 2024
VAN DER ZANT FM, Wondergem M, Broos WAM, Lazarenko SV, et al Frequency and characteristics of ectopic parathyroid adenomas in a cohort of
patients referred for 18F-fluorocholine PET/CT.
Nucl Med Commun. 2024 Oct 22. doi: 10.1097/MNM.0000000000001920. PubMedAbstract available
STOFFELS M, Cousin F, Lamande M, Denis C, et al Characterization of exclusive rib lesions detected by [68Ga]Ga-PSMA-11 PET/CT.
Nucl Med Commun. 2024 Oct 21. doi: 10.1097/MNM.0000000000001919. PubMedAbstract available
OZMAN O, Veerman H, Hagens MJ, van Leeuwen PJ, et al The effect of PSMA PET/CT on clinical decision-making of radical prostatectomy
and pelvic lymph node dissection.
Nucl Med Commun. 2024 Oct 17. doi: 10.1097/MNM.0000000000001916. PubMedAbstract available
MURRAY AW, Scuffham JW, Dickson JC, Memmott M, et al UK national survey on nuclear medicine in-house clinical software: the calm
before the storm.
Nucl Med Commun. 2024 Oct 16. doi: 10.1097/MNM.0000000000001917. PubMedAbstract available
JIANG C, Zhao M, Zhang W Application of 18F-fluorodeoxyglucose PET/computed tomography in the diagnosis of
infiltrative subsolid nodules in lung adenocarcinoma.
Nucl Med Commun. 2024 Oct 16. doi: 10.1097/MNM.0000000000001908. PubMedAbstract available
JIA Q, Wang A, Liu Y, Fan Y, et al Diagnostic value of baseline 18F-FDG PET/CT and peripheral blood inflammatory
markers for aggressive lymphoma in non-Hodgkin's lymphoma.
Nucl Med Commun. 2024 Oct 15. doi: 10.1097/MNM.0000000000001912. PubMedAbstract available
ORTEGA C, Anconina R, Joshi S, Metser U, et al Combination of FDG PET/CT radiomics and clinical parameters for outcome
prediction in patients with non-Hodgkin's lymphoma.
Nucl Med Commun. 2024 Oct 15. doi: 10.1097/MNM.0000000000001895. PubMedAbstract available
YANG S, Ma R, Wu J The diagnostic value of combining preoperative serum CA19-9, ALBI score, and
18F-FDG PET/CT imaging in preoperative resectability of pancreatic cancer.
Nucl Med Commun. 2024 Oct 4. doi: 10.1097/MNM.0000000000001910. PubMedAbstract available
MU X, Lu L, Li J, Zhang L, et al Low false-positive lymph nodes for 18F-fibroblast activation protein inhibitors
PET/computed tomography in preoperative staging of patients with nonsmall cell
lung cancer.
Nucl Med Commun. 2024 Oct 4. doi: 10.1097/MNM.0000000000001913. PubMedAbstract available
KARAOGLAN H, Kepenek F, Komek H, Kaplan I, et al The prognostic role of whole-body volumetric positron emission
tomography/computed tomography parameters in treatment naive colorectal cancer
patients with liver metastases.
Nucl Med Commun. 2024 Oct 2. doi: 10.1097/MNM.0000000000001915. PubMedAbstract available
LI J, Cui N, Wang Y, Li W, et al Prediction of preoperative lymph-vascular space invasion and survival outcomes of
cervical squamous cell carcinoma by utilizing 18F-FDG PET/CT imaging at early
stage.
Nucl Med Commun. 2024 Oct 2. doi: 10.1097/MNM.0000000000001909. PubMedAbstract available
SEN AE, Kaya B, Bozcuk HS, Sahin O, et al Evaluation of brain metabolism using F18-FDG PET/CT imaging in patients diagnosed
with lung cancer.
Nucl Med Commun. 2024 Oct 2. doi: 10.1097/MNM.0000000000001911. PubMedAbstract available
KOTE R, Ravina M, Goyal H, Mohanty D, et al Role of textural and radiomic analysis parameters in predicting histopathological
parameters of the tumor in breast cancer patients.
Nucl Med Commun. 2024;45:835-847. PubMedAbstract available
ULRICH M, Lehnick D, Strobel K, Grunig H, et al Quantitative bone single photon emission computed tomography/computed tomography
in symptomatic and asymptomatic foot and ankle osteoarthritis.
Nucl Med Commun. 2024;45:848-857. PubMedAbstract available
September 2024
AN EJ, Kim JB, Son J, Jeong SY, et al Deep learning-based binary classification of beta-amyloid plaques using 18F
florapronol PET.
Nucl Med Commun. 2024 Sep 27. doi: 10.1097/MNM.0000000000001904. PubMedAbstract available
PALANISWAMY SS, Subramanyam P Diagnostic performance of simultaneous PET-magnetic resonance versus PET-computed
tomography in oncology with an overview on clinical utility and referral pattern
of PET-magnetic resonance: a single institutional study.
Nucl Med Commun. 2024 Sep 26. doi: 10.1097/MNM.0000000000001900. PubMedAbstract available
WANG X, Yang C, Wang X, Wang D, et al Predicting invasiveness of ground-glass nodules in lung adenocarcinoma: based on
preoperative 18F-fluorodeoxyglucose PET/computed tomography and high-resolution
computed tomography.
Nucl Med Commun. 2024 Sep 18. doi: 10.1097/MNM.0000000000001898. PubMedAbstract available
WU F, Cao G, Lu J, Ye S, et al Correlation between 18F-FDG PET/CT metabolic parameters and microvascular
invasion before liver transplantation in patients with hepatocellular carcinoma.
Nucl Med Commun. 2024 Sep 13. doi: 10.1097/MNM.0000000000001897. PubMedAbstract available
ZEYDAN B, Johnson DR, Schwarz CG, Przybelski SA, et al Visual assessments of 11C-Pittsburgh compound-B PET vs. 18F-flutemetamol PET
across the age spectrum.
Nucl Med Commun. 2024 Sep 13. doi: 10.1097/MNM.0000000000001902. PubMedAbstract available
SHIRAI A, Ogura I Evaluation of jaw pathologies of patients with medication-related osteonecrosis
of the jaw using a computer program to assess the bone scan index: comparison of
standardized uptake values with bone SPECT/CT.
Nucl Med Commun. 2024 Sep 12. doi: 10.1097/MNM.0000000000001896. PubMedAbstract available
DORRI GIV M, Arabi H, Naseri S, Alipour Firouzabad L, et al Evaluation of the prostate cancer and its metastases in the [68Ga]Ga-PSMA PET/CT
images: deep learning method vs. conventional PET/CT processing.
Nucl Med Commun. 2024 Sep 3. doi: 10.1097/MNM.0000000000001891. PubMedAbstract available
IZADI MA, Alemohammad N, Geramifar P, Salimi A, et al Automatic detection and segmentation of lesions in 18F-FDG PET/CT imaging of
patients with Hodgkin lymphoma using 3D dense U-Net.
Nucl Med Commun. 2024 Sep 3. doi: 10.1097/MNM.0000000000001892. PubMedAbstract available
August 2024
NASR H, Alnajashi N, Farghaly H, Alqarni A, et al 18F FDG PET/CT versus 99m Tc MDP Bone scintigraphy in imaging of metastatic
osseous disease in breast cancer patients; Solving the discrepancies in light of
serum markers.
Nucl Med Commun. 2024 Aug 22. doi: 10.1097/MNM.0000000000001888. PubMedAbstract available
LEE I, Byun BH, Kim BI, Choi CW, et al Evaluating 64Cu-DOTA-rituximab as a PET agent in patients with B-cell lymphoma: a
head-to-head comparison with 18F-fluorodeoxyglucose PET/computed tomography.
Nucl Med Commun. 2024 Aug 19. doi: 10.1097/MNM.0000000000001889. PubMedAbstract available
BIBEAU-DELISLE A, Bouabdallaoui N, Lamarche C, Harel F, et al Assessment of renal perfusion with 82-rubidium PET in patients with normal and
abnormal renal function.
Nucl Med Commun. 2024 Aug 19. doi: 10.1097/MNM.0000000000001890. PubMedAbstract available
LANG J, Liu W, Liu G, Liu S, et al Prognostic value of 18F-FDG PET/CT in postoperative recurrence of retroperitoneal
liposarcoma: a single-center retrospective study.
Nucl Med Commun. 2024 Aug 8. doi: 10.1097/MNM.0000000000001886. PubMedAbstract available
CZIBOR S, Csatlos Z, Fabian K, Piroska M, et al Volumetric and textural analysis of PET/CT in patients with diffuse large B-cell
lymphoma highlights the importance of novel MTVrate feature.
Nucl Med Commun. 2024 Aug 2. doi: 10.1097/MNM.0000000000001884. PubMedAbstract available
GUO L, Wang R, Shen G Fluorine-18 fluorodeoxyglucose uptake change in liver, mediastinal blood pool,
and lymphoid cell-rich organs during programmed cell death-1 immunotherapy in
lymphoma.
Nucl Med Commun. 2024;45:718-726. PubMedAbstract available
July 2024
FRAGKIADAKI V, Panagiotidis E, Vlontzou E, Kalathas T, et al Correlation of PSA blood levels with standard uptake value maximum (SUVmax) and
total metabolic tumor volume (TMTV) in 18F-PSMA-1007 and 18F-choline PET/CT in
patients with biochemically recurrent prostate cancer.
Nucl Med Commun. 2024 Jul 30. doi: 10.1097/MNM.0000000000001881. PubMedAbstract available
KALSHETTY A, Nazar A, Vimalnath KV, Chakravarty R, et al [64Cu]Copper chloride PET-CT: a comparative evaluation of fasting and non-fasting
states in patients of prostate carcinoma.
Nucl Med Commun. 2024 Jul 30. doi: 10.1097/MNM.0000000000001882. PubMedAbstract available
USMANI S, Al Riyami K, Jain A, Alajmi AA, et al Enhancing precision in bone metastasis diagnosis for lobular breast cancer:
reassessing the role of 18F-FDG PET/CT.
Nucl Med Commun. 2024 Jul 22. doi: 10.1097/MNM.0000000000001880. PubMedAbstract available
NOTGHI A Dr. Leslie Keith Harding (3 February 1939 - 14 September 2023).
Nucl Med Commun. 2024;45:650. PubMed
ERDOGAN EB, Tekce E, Koca S, Aslan N, et al Predictive significance of intraprostatic volumetric parameters derived from
early and standard time 68Ga-PSMA PET/CT images in newly diagnosed prostate
cancer patients.
Nucl Med Commun. 2024;45:629-641. PubMedAbstract available
ALONGI P, Messina M, Pepe A, Arnone A, et al Prostate-specific membrane antigen-PET/CT may result in stage migration in
prostate cancer: performances, quantitative analysis, and potential criticism in
the clinical practice.
Nucl Med Commun. 2024;45:622-628. PubMedAbstract available
NOTGHI A, James G, O'Brien J, Arasaradnam R, et al British Nuclear Medicine Society SeHCAT guidelines.
Nucl Med Commun. 2024;45:564-572. PubMed
ISHII S, Sugawara S, Tanaka Y, Kawamoto N, et al Impact of iodine contrast media on gamma camera-based GFR and factors affecting
the difference between serum creatinine-based estimated GFR and Gate's GFR.
Nucl Med Commun. 2024;45:573-580. PubMedAbstract available
June 2024
LITTLE D, Graham R, Redman S BNMS guidelines for Nuclear Medicine Events and Learning Meetings: principles for
departmental learning from unforeseen events.
Nucl Med Commun. 2024 Jun 27. doi: 10.1097/MNM.0000000000001876. PubMed
CHANDEKAR KR, Satapathy S, Singh H, Kumar R, et al Utility of PSMA-PET derived volumetric parameters in initial risk stratification
and prediction of prostate cancer metastasis - a head-to-head comparison of the
radiotracers 18F-PSMA-1007 and 68Ga-PSMA-11.
Nucl Med Commun. 2024 Jun 27. doi: 10.1097/MNM.0000000000001874. PubMedAbstract available
PETERS AM The physiological basis of renal nuclear medicine.
Nucl Med Commun. 2024 Jun 21. doi: 10.1097/MNM.0000000000001872. PubMedAbstract available
MOHEBBI A, Kiani I, Mohammadzadeh S, Mirza-Aghazadeh-Attari M, et al Enhanced staging of extrahepatic hepatocellular carcinoma metastasis through
dual-tracer PET/computed tomography: a systematic review and meta-analysis.
Nucl Med Commun. 2024 Jun 19. doi: 10.1097/MNM.0000000000001870. PubMedAbstract available
ALENEZI S, Dannoon S, Alnafisi N, Elgazzar A, et al Hyperostosis frontalis interna on fluorine-18 sodium fluoride PET/computed
tomography of obese cancer patients: a potential mimicker of metastasis.
Nucl Med Commun. 2024 Jun 14. doi: 10.1097/MNM.0000000000001873. PubMedAbstract available
MLV SK, Mittal R, Chauhan N, Kumar R, et al Evaluation of the metabolic activity of the torn rotator cuff muscles by
18F-2-deoxy-d-glucose PET-computed tomography scan.
Nucl Med Commun. 2024 Jun 14. doi: 10.1097/MNM.0000000000001871. PubMedAbstract available
SONAVANE S, Salvi O, Asopa RV, Basu S, et al Assessing Krenning's score on 68Ga-DOTATATE PET-CT and miPSMA score on
68Ga-PSMA-11 PET-CT in TENIS: a comparison with FDG PET/CT and examining the
feasibility of targeted radionuclide therapy.
Nucl Med Commun. 2024 Jun 3. doi: 10.1097/MNM.0000000000001856. PubMedAbstract available
PANAGIOTIDIS E, Andreou S, Paschali A, Angeioplasti K, et al Towards improved diagnosis: radiomics and quantitative biomarkers in
18F-PSMA-1007 and 18F-fluorocholine PET/CT for prostate cancer recurrence.
Nucl Med Commun. 2024 Jun 3. doi: 10.1097/MNM.0000000000001867. PubMedAbstract available
IDE BOLET S, Sisti J, Cheng K, Dadparvar S, et al Quantitative Lobar Tc99m-MAA SPECT/CT of the Lung in pre-and post-procedural
guidance for Bronchoscopic Lung Volume Reduction.
Nucl Med Commun. 2024 Jun 3. doi: 10.1097/MNM.0000000000001868. PubMedAbstract available
SCUFFHAM JW, Dickson JC, Murray A, Flux GD, et al Commentary on the current status of nuclear medicine medical physics expert
support in the UK.
Nucl Med Commun. 2024;45:541-545. PubMed
WICKS S, Levart D, Conway L, Heraghty N, et al Noninvasive measurement of tracer extraction efficiency in tissue, illustrated
with Tc-99m-MAG3.
Nucl Med Commun. 2024;45:519-525. PubMedAbstract available
ADIN ME, Isufi E, Wu J, Pang Y, et al Reactive axillary lymph nodes after COVID-19 mRNA vaccination: comparison of mRNA
vs. attenuated whole-virus vaccines.
Nucl Med Commun. 2024;45:474-480. PubMedAbstract available
DILAWAR H, Habib S, Rana R, Ahmed A, et al Comparison of absolute renal uptake by using Tc-99m MAG-3 and Tc-99m DMSA.
Nucl Med Commun. 2024;45:481-486. PubMedAbstract available
May 2024
HU Y, Guo D, Zhu Z, Lu L, et al The value of dual time-point fluorine-18 fluorodeoxyglucose PET/computed
tomography imaging in predicting lymph node metastasis in non-small cell lung
cancer patients.
Nucl Med Commun. 2024 May 27. doi: 10.1097/MNM.0000000000001866. PubMedAbstract available
SPILIOTOPOULOU M, Papathanasiou N, Labieniec L, Papachristou E, et al 99mTc-DTPA dynamic SPECT/CT renogram in adults: feasibility and diagnostic
benefit.
Nucl Med Commun. 2024 May 23. doi: 10.1097/MNM.0000000000001865. PubMedAbstract available
MITITELU R, Mitoi A, Mazilu C, Jinga M, et al Advancements in hepatocellular carcinoma management: the role of 18F-FDG PET-CT
in diagnosing portal vein tumor thrombosis.
Nucl Med Commun. 2024 May 17. doi: 10.1097/MNM.0000000000001863. PubMedAbstract available
KHAN D, Phulia A, Kumar S, Sarswat S, et al Role of 18F-FDG PET/CT for providing a targeted approach for etiology of PUO.
Nucl Med Commun. 2024 May 17. doi: 10.1097/MNM.0000000000001855. PubMedAbstract available
PAN Q, Cao X, Li J, Li F, et al Different extramedullary disease shown in chemokine receptor 4 targeted PET/CT
with [68Ga]Ga-pentixafor in patients with Waldenstrom macroglobulinemia and
smoldering disease.
Nucl Med Commun. 2024 May 15. doi: 10.1097/MNM.0000000000001862. PubMedAbstract available
FILIZOGLU N, Ozguven S, Akin Telli T, Ones T, et al Defining the optimal segmentation method for measuring somatostatin receptor
expressing tumor volume on 68Ga-DOTATATE positron emission tomography/computed
tomography to predict prognosis in patients with gastroenteropancreatic
neuroendocrine tumors.
Nucl Med Commun. 2024 May 15. doi: 10.1097/MNM.0000000000001861. PubMedAbstract available
PEIX A, Jimenez-Heffernan A, Devasenapathy N, Sobic-Saranovic D, et al Correlates of markers of dyssynchrony in patients with STEMI and multivessel
disease: an analysis from the IAEA SPECT STEMI trial.
Nucl Med Commun. 2024 May 15. doi: 10.1097/MNM.0000000000001860. PubMedAbstract available
LAU JHY, Ng KK, Wong WC, Ng KS, et al Retrospective study of qualitative assessment in detecting synchronous and
metachronous malignancies in adult cancer patients by 18F-FDG PET/CT.
Nucl Med Commun. 2024 May 10. doi: 10.1097/MNM.0000000000001857. PubMedAbstract available
British Nuclear Medicine Society Spring Meeting 13th - 15th May 2024.
Nucl Med Commun. 2024;45:420-461. PubMed
KIAN ARA H, Alemohammad N, Paymani Z, Ebrahimi M, et al Machine learning diagnosis of active Juvenile Idiopathic Arthritis on blood pool
[ 99M Tc] Tc-MDP scintigraphy images.
Nucl Med Commun. 2024;45:355-361. PubMedAbstract available
April 2024
JAIN Y, Agrawal A, Joshi A, Menon S, et al Can 18F FDG PET/CT metabolic parameters be used to noninvasively differentiate
between different histopathological subtypes and Fuhrman grades of renal cell
cancer?
Nucl Med Commun. 2024 Apr 30. doi: 10.1097/MNM.0000000000001844. PubMedAbstract available
WANG B, Zhao X, Liu Y, Zhang Z, et al Comparison of 68Ga-FAPI-04 PET/CT with 18F-FDG PET/CT for diagnosis and staging
of gastric and colorectal cancer.
Nucl Med Commun. 2024 Apr 29. doi: 10.1097/MNM.0000000000001845. PubMedAbstract available
AL-IBRAHEEM A, Allouzi S, Abdlkadir AS, Mikhail-Lette M, et al PET/CT in leukemia: utility and future directions.
Nucl Med Commun. 2024 Apr 22. doi: 10.1097/MNM.0000000000001846. PubMedAbstract available
BESTETTI A, Zangheri B, Gabanelli SV, Parini V, et al Union is strength: the combination of radiomics features and 3D-deep learning in
a sole model increases diagnostic accuracy in demented patients: a whole brain
18FDG PET-CT analysis.
Nucl Med Commun. 2024 Apr 18. doi: 10.1097/MNM.0000000000001853. PubMedAbstract available
MUT F, Gaudiano MP, Kapitan M Relationship between transient ischemic dilatation and changes in heart rate
during gated SPECT acquisition in a low-risk population without perfusion
defects.
Nucl Med Commun. 2024 Apr 15. doi: 10.1097/MNM.0000000000001852. PubMedAbstract available
SAXENA A, Subramanyam P, Sarma M, Bhad B, et al 18F-FDG PET imaging for treatment response assessment and management guidance in
patients with skull base osteomyelitis.
Nucl Med Commun. 2024 Apr 15. doi: 10.1097/MNM.0000000000001847. PubMedAbstract available
KUMAR P, Arora P, Kumar R, Singh H, et al Evaluation of skull bone viability and effect of early surgical intervention in
electrical contact burns using 18F-Sodium Fluoride PET-CT imaging.
Nucl Med Commun. 2024 Apr 9. doi: 10.1097/MNM.0000000000001842. PubMedAbstract available
Role of textural analysis parameters derived from FDG PET/CT in differentiating
hepatocellular carcinoma and hepatic metastases: Erratum.
Nucl Med Commun. 2024;45:353. PubMed
GIBBONS T, Perkins A, Barnett J Safety, biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 99m
Tc-maraciclatide in healthy volunteers.
Nucl Med Commun. 2024;45:295-303. PubMedAbstract available
March 2024
GREEN A, Temsah P, Goldfarb L, Sanfolippo K, et al Evaluating appropriateness of 18F-fluciclovine PET/CT relative to standard of
care imaging guidelines and the impact of ADT on positivity: a prospective study
in 62 Veterans Administration patients at a single institution.
Nucl Med Commun. 2024 Mar 22. doi: 10.1097/MNM.0000000000001836. PubMedAbstract available
JALILIFAR M, Sadeghi M, Emami-Ardekani A, Geravand K, et al Quantifying partial volume effect in SPECT and planar imaging: optimizing region
of interest for activity concentration estimation in different sphere sizes.
Nucl Med Commun. 2024 Mar 20. doi: 10.1097/MNM.0000000000001835. PubMedAbstract available
GONDHANE A, Verma P, Chandak A, Basu S, et al Prospective evaluation of 68Ga-NODAGA-RGD PET-CT in patients of carcinoma thyroid
with thyroglobulin elevated negative radioiodine scintigraphy (TENIS) with a
head-to-head comparison with FDG-PET/CT.
Nucl Med Commun. 2024 Mar 6. doi: 10.1097/MNM.0000000000001828. PubMedAbstract available
AL-NAHHAS A, Jawad ASM F-18-FDG PET-CT in investigating possible malignancy associated with rheumatic
disease: beware of excessive radiation.
Nucl Med Commun. 2024 Mar 6. doi: 10.1097/MNM.0000000000001834. PubMed
PARKER JA, Tahir MM, Whitmarsh SR, Sarwar A, et al Free mebrofenin clearance.
Nucl Med Commun. 2024;45:175-180. PubMedAbstract available
February 2024
FUKUSHIMA Y, Suzuki K, Kim M, Gu W, et al Evaluation of bone marrow invasion on the machine learning of 18F-FDG PET texture
analysis in lower gingival squamous cell carcinoma.
Nucl Med Commun. 2024 Feb 19. doi: 10.1097/MNM.0000000000001826. PubMedAbstract available
DIZDAREVIC S, Mccready VR, Blower PJ, Voo SA, et al The British nuclear medicine research strategy - the framework.
Nucl Med Commun. 2024 Feb 19. doi: 10.1097/MNM.0000000000001827. PubMedAbstract available
PEI Y, Wang Z, Hao S, Tong Y, et al Analyzing the value of delayed 18F-FDG PET/CT images in diagnosing small
colorectal cancer liver metastases in patients with hypothyroidism based on
diagnostic accuracy and image standardized uptake value.
Nucl Med Commun. 2024 Feb 19. doi: 10.1097/MNM.0000000000001825. PubMedAbstract available
JONMARKER O, Nilsson T, Axelsson R, Ericson LH, et al [ 18 F]-PSMA-1007 PET imaging optimization and inter-rater reliability - a
comparison of three different reconstructions read by four radiologists.
Nucl Med Commun. 2024 Feb 5. doi: 10.1097/MNM.0000000000001823. PubMedAbstract available
YANG H, Liu X, Wang L, Zhou W, et al 18F-FDG PET/CT characteristics of IASLC grade 3 invasive adenocarcinoma and the
value of 18F-FDG PET/CT for preoperative prediction: a new prognostication model.
Nucl Med Commun. 2024 Feb 5. doi: 10.1097/MNM.0000000000001819. PubMedAbstract available
WANG M, Peng M, Yang X, Zhang Y, et al Preoperative prediction of microsatellite instability status: development and
validation of a pan-cancer PET/CT-based radiomics model.
Nucl Med Commun. 2024 Feb 5. doi: 10.1097/MNM.0000000000001816. PubMedAbstract available
PARGHANE RV, Suralkar T, Nikam D, Basu S, et al Evaluation of prostate-specific membrane antigen expression in locally advanced
or metastatic breast carcinoma with 68Ga-PSMA-11 positron-emission
tomography/computed tomography imaging for potential theranostics.
Nucl Med Commun. 2024 Feb 5. doi: 10.1097/MNM.0000000000001820. PubMedAbstract available
PUJATTI PB, Dos Santos JPG, Gomes ML, Cardoso MAS, et al A comparative study on the quality of in vivo labeled red blood cell radionuclide
ventriculography images employing different freeze-dried reagents.
Nucl Med Commun. 2024;45:155-160. PubMedAbstract available
January 2024
WECHALEKAR K, Hutt D, Quigley AM, Whelan C, et al Recommendations for good clinical practice for DPD bone scintigraphy for cardiac
amyloidosis.
Nucl Med Commun. 2024 Jan 26. doi: 10.1097/MNM.0000000000001796. PubMed
VINJAMURI S, Pant V, Bomanji JB, Marengo M, et al Assessing nuclear medicine practices: a critical evaluation of QUANUM through a
quality improvement perspective and its wider relevance.
Nucl Med Commun. 2024 Jan 22. doi: 10.1097/MNM.0000000000001815. PubMedAbstract available
OUCHI Y, Kishino T, Miyashita T, Mori T, et al Predictive value of local control by 4'-[methyl-11C]-thiotymidine PET volume
parameters in p16-negative oropharyngeal, hypopharyngeal, and supraglottic
squamous cell carcinoma.
Nucl Med Commun. 2024 Jan 22. doi: 10.1097/MNM.0000000000001821. PubMedAbstract available
THOMSON WH Using VARSKIN+v1.2 to estimate dose from direct skin contamination with
radionuclides 223Ra, 212Pb and 225Ac; considerations for Nuclear Medicine staff
and associated Personal Protective Equipment (PPE).
Nucl Med Commun. 2024 Jan 19. doi: 10.1097/MNM.0000000000001808. PubMedAbstract available
CONRAD TJ, Lau HX, Yerkovich ST, Alghamry A, et al Ventilation-perfusion scan for diagnosing pulmonary embolism: do chest x-rays
matter?
Nucl Med Commun. 2024 Jan 19. doi: 10.1097/MNM.0000000000001802. PubMedAbstract available
ESEONU K, Oduoza U, Robinson P, Easty M, et al Bone scintigraphy with SPECT/CT in paediatric patients with neck and back pain in
comparison with other imaging modalities: the experience of a tertiary paediatric
referral centre.
Nucl Med Commun. 2024 Jan 12. doi: 10.1097/MNM.0000000000001811. PubMedAbstract available
MANAFI-FARID R, Mahini M, Mirshahvalad SA, Fallahi B, et al Diagnostic value of [68Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot
study.
Nucl Med Commun. 2024 Jan 12. doi: 10.1097/MNM.0000000000001806. PubMedAbstract available
KESIM S, Balaban Genc ZC, Soydemir E, Baltacioglu F, et al Evaluating therapeutic efficacy of extended shelf-life 90Y glass microspheres in
transarterial radioembolization for colorectal cancer: a quantitative FDG PET/CT
analysis.
Nucl Med Commun. 2024 Jan 12. doi: 10.1097/MNM.0000000000001813. PubMedAbstract available
BESTETTI A, Calabrese L, Parini V, Fornara C, et al Greater accuracy of radiomics compared to deep learning to discriminate normal
subjects from patients with dementia: a whole brain 18FDG PET analysis.
Nucl Med Commun. 2024 Jan 8. doi: 10.1097/MNM.0000000000001810. PubMedAbstract available
LU Y, Kumbhar S, Liu Y, Vo NJ, et al Assessment of infant gonadal dose irradiated from urine-contaminated diapers
during diuretic renal scintigraphy.
Nucl Med Commun. 2024;45:45-50. PubMedAbstract available
KAVURGACI S, Ozmen O, Tatci E, Soyler Y, et al Potential role of pre-treatment bone marrow SUVmean to liver SUVmean ratio (BM/L)
and comparison of primary tumour FDG uptake with brain FDG uptake in predicting
survival in limited-stage lung cancers.
Nucl Med Commun. 2024;45:77-85. PubMedAbstract available
December 2023
ONAL C, Guler OC, Torun N, Reyhan M, et al Long-term assessment of clinical parameters and positron emission tomography
parameters in predicting recurrence in uterine cervical cancer patients receiving
definitive chemoradiotherapy.
Nucl Med Commun. 2023 Dec 28. doi: 10.1097/MNM.0000000000001800. PubMedAbstract available
AGAOGLU SANLI B, Duman E, Gulmez B, Aguloglu N, et al Evaluation of the effect of PET/CT Fluorodeoxyglucose inclusion on mortality and
survival in operated thymoma patients.
Nucl Med Commun. 2023 Dec 28. doi: 10.1097/MNM.0000000000001805. PubMedAbstract available
AN S, Huang G, Yu X, Liu J, et al The added diagnostic value of 18F-FDG PET/CT radiomic analysis in multiple
myeloma patients with negative visual analysis.
Nucl Med Commun. 2023 Dec 28. doi: 10.1097/MNM.0000000000001809. PubMedAbstract available
BABERWAL P, Sonavane S, Vimalnath KV, Chakravarty R, et al Normal physiological distribution and tumor localization of 64CuCl2 in different
human malignancies along with semiquantitative scoring: a comparative evaluation
with 18Fluorodeoxyglucose (18FDG) PET-CT.
Nucl Med Commun. 2023 Dec 28. doi: 10.1097/MNM.0000000000001804. PubMedAbstract available
WU KC, Chen SW, Hsieh TC, Yen KY, et al Early prediction of distant metastasis in patients with uterine cervical cancer
treated with definitive chemoradiotherapy by deep learning using pretreatment
[18F]fluorodeoxyglucose positron emission tomography/computed tomography.
Nucl Med Commun. 2023 Dec 27. doi: 10.1097/MNM.0000000000001799. PubMedAbstract available
JENA SR, Watts A, Aggarwal P, Bachhal V, et al 68Ga-Pentixafor PET/CT for in-vivo mapping of CXCR4 receptors as potential
radiotheranostic targets in soft tissue and bone sarcoma: preliminary results.
Nucl Med Commun. 2023 Dec 27. doi: 10.1097/MNM.0000000000001803. PubMedAbstract available
XU M, Gu B, Zhang J, Xu X, et al Differentiation of cancer of unknown primary and lymphoma in head and neck
metastatic poorly differentiated cancer using 18F-FDG PET/CT tumor metabolic
heterogeneity index.
Nucl Med Commun. 2023 Dec 14. doi: 10.1097/MNM.0000000000001797. PubMedAbstract available
SHARMA A, Garg A, Singh M, Sharma MC, et al Metabolic imaging in recurrent gliomas: comparative performance of 18F-FDOPA,
18F-fluorocholine and 18F-FDG PET/CT.
Nucl Med Commun. 2023 Dec 14. doi: 10.1097/MNM.0000000000001795. PubMedAbstract available
British Nuclear Medicine Society Autumn Meeting 2023.
Nucl Med Commun. 2023;44:1191-1214. PubMed
MCMEEKIN HJ, Peters AM, Burniston MT, Vadrucci M, et al Quantitative lymphoscintigraphy of the lower limbs for the diagnosis of
phlebolymphoedema.
Nucl Med Commun. 2023;44:1080-1086. PubMedAbstract available
SAGAR S, Kaushik P, Phulia A, Khan D, et al Diagnostic accuracy of RBC scintigraphy and CTA for detection of patients with
suspected lower gastrointestinal bleeding: a systematic review and meta-analysis.
Nucl Med Commun. 2023;44:1074-1079. PubMedAbstract available
MARTINEAU PJ, Pelletier-Galarneau M, Slomka P, Goertzen AL, et al Optimizing stress-only myocardial perfusion imaging: a clinical prediction model
to improve patient selection.
Nucl Med Commun. 2023;44:1087-1093. PubMedAbstract available
November 2023
KAUR K, Nagi S, Satapathy S, Aggarwal P, et al Estimation of absorbed dose to salivary glands in mCRPC patients undergoing 177
Lu- PSMA-617 radioligand therapy using quantitative SPECT-CT at single time
point: a single-center feasibility study.
Nucl Med Commun. 2023 Nov 20. doi: 10.1097/MNM.0000000000001792. PubMedAbstract available
KALRA S, Tripathi M, Tripathi M, Sonar RS, et al Role of FDG PET/CT in definitive and presumed autoimmune encephalitis.
Nucl Med Commun. 2023 Nov 20. doi: 10.1097/MNM.0000000000001790. PubMedAbstract available
VALKEMA MJ, de Lussanet de la Sabloniere QG, Valkema R, Thomeer MGJ, et al 18F-FDG PET/MRI for restaging esophageal cancer after neoadjuvant
chemoradiotherapy.
Nucl Med Commun. 2023 Nov 20. doi: 10.1097/MNM.0000000000001793. PubMedAbstract available
October 2023
KIM SJ, Park CY, Kwon H, Kim YH, et al Evaluation of adrenal masses using 18F-FDOPA PET/CT in patients suspected with
pheochromocytoma.
Nucl Med Commun. 2023 Oct 30. doi: 10.1097/MNM.0000000000001781. PubMedAbstract available
COOK GJ, Dickson J, Chicklore S, Dempsey M, et al BNMS UK PET standards.
Nucl Med Commun. 2023 Oct 30. doi: 10.1097/MNM.0000000000001779. PubMed
PANAGIOTIDIS E, Papachristou K, Makridou A, Zoglopitou LA, et al Review of artificial intelligence clinical applications in Nuclear Medicine.
Nucl Med Commun. 2023 Oct 30. doi: 10.1097/MNM.0000000000001786. PubMedAbstract available
SAGARA H, Inoue K, Yaku H, Ohsawa A, et al A new simpler image quality index based on body size for FDG-PET/CT.
Nucl Med Commun. 2023 Oct 30. doi: 10.1097/MNM.0000000000001787. PubMedAbstract available
HERNANDEZ MC, Yazaki P, Mortimer JE, Yamauchi D, et al Pilot study of HER2 targeted 64Cu-DOTA-tagged PET imaging in gastric cancer
patients.
Nucl Med Commun. 2023 Oct 30. doi: 10.1097/MNM.0000000000001761. PubMedAbstract available
MILOSEVIC A, Styczen H, Haubold J, Kessler L, et al Correlation of the apparent diffusion coefficient with the standardized uptake
value in meningioma of the skull plane using [68]Ga-DOTATOC PET/MRI.
Nucl Med Commun. 2023 Oct 12. doi: 10.1097/MNM.0000000000001774. PubMedAbstract available
WANG F, Yuan H, Lv J, Han X, et al Stress-only versus rest-stress SPECT MPI in the detection and diagnosis of
myocardial ischemia and infarction by machine learning.
Nucl Med Commun. 2023 Oct 12. doi: 10.1097/MNM.0000000000001782. PubMedAbstract available
ZHAO M, Zan K, Cui X, Chai L, et al Investigation of the quarter-dose 18F-FDG total-body PET in routine clinical
practice and its clinical value.
Nucl Med Commun. 2023 Oct 12. doi: 10.1097/MNM.0000000000001777. PubMedAbstract available
RAJU S, Sharma A, Kumar S, Seth A, et al Impact of forced diuresis at two different time points on pelvic imaging in
prostatic carcinoma with 68Ga-PSMA PET/CT.
Nucl Med Commun. 2023 Oct 5. doi: 10.1097/MNM.0000000000001771. PubMedAbstract available
PANAGIOTIDIS E, Fragkiadaki V, Papathanasiou N, Kypraios C, et al Comparison of 18F-PSMA-1007 and 18F-Choline PET/CT in prostate cancer patients
with biochemical recurrence: a phase 3, prospective, multicenter, randomized
study.
Nucl Med Commun. 2023 Oct 2. doi: 10.1097/MNM.0000000000001770. PubMedAbstract available
CISTARO A, Quartuccio N, Piccardo A, Meo G, et al Brain positron emission tomography in idiopathic normal-pressure hydrocephalus:
new 18F-fluorodeoxyglucose pattern in a long-known syndrome.
Nucl Med Commun. 2023 Oct 2. doi: 10.1097/MNM.0000000000001763. PubMedAbstract available
MCCREADY R, Dizdarevic S Acronyms in Nuclear Medicine (AINM).
Nucl Med Commun. 2023;44:926. PubMed
HAIDAR M, Jazra D, Kassas M Challenging false positive findings in 68Ga-FAPI PET: insights from a clinical
case.
Nucl Med Commun. 2023;44:924-926. PubMed
AKTAS A, Baskin E, Gencoglu EA, Colak T, et al Comparison of parathyroid scintigraphy findings in pediatric and adult patients
with secondary hyperparathyroidism.
Nucl Med Commun. 2023;44:860-863. PubMedAbstract available
GHAEDIAN T, Abdinejad M, Nasrollahi H, Ghaedian M, et al Comparing the role of 99m Tc-HYNIC-PSMA-11 and 99m Tc-MDP scintigraphy for the
initial staging of intermediate to high-risk prostate cancer.
Nucl Med Commun. 2023;44:864-869. PubMedAbstract available
MISSIR E, Begley P, Jessop M, Singh N, et al Quantitative [123]I-Ioflupane DaTSCAN single-photon computed tomography-computed
tomography in Parkinsonism.
Nucl Med Commun. 2023;44:843-853. PubMedAbstract available
September 2023
LI P, Zhang Y, Xu T, Zhu J, et al Sensitivities evaluation of five radiopharmaceuticals in four common medullary
thyroid carcinoma metastatic sites on PET/CT: a network meta-analysis and
systematic review.
Nucl Med Commun. 2023 Sep 29. doi: 10.1097/MNM.0000000000001773. PubMedAbstract available
LUE KH, Chen YH, Chu SC, Chang BS, et al A comparison of 18F-FDG PET-based radiomics and deep learning in predicting
regional lymph node metastasis in patients with resectable lung adenocarcinoma: a
cross-scanner and temporal validation study.
Nucl Med Commun. 2023 Sep 21. doi: 10.1097/MNM.0000000000001776. PubMedAbstract available
MCQUAID SJ The impact of total body PET.
Nucl Med Commun. 2023 Sep 21. doi: 10.1097/MNM.0000000000001772. PubMed
BIN ESSA N, Kaplar Z, Balaji N, Alduraibi A, et al PET/CT in treatment response assessment in lung cancer. When should it be
recommended?
Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001757. PubMedAbstract available
WAMASING N, Nakamura S, Watanabe H, Kuribayashi A, et al Potential of preoperative fluorodeoxyglucose-positron emission
tomography/computed tomography to diagnose contralateral lymph node metastases in
patients with oral cancer.
Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001765. PubMedAbstract available
WANG H, Xie X, Duan Y, Chai L, et al Rabbit systemic glucose metabolism map by total-body dynamic PET/CT technology.
Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001767. PubMedAbstract available
HAIDAR M, Kassas M, Chehade F, Chahinian R, et al The role of 18F-FDG-PET/CT in the management of differentiated thyroid cancer.
Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001758. PubMedAbstract available
GHOSH S, Agrawal A, Rangarajan V, Choudhury S, et al Evaluation of post-chemotherapy residual seminomatous masses by
18F-fluorodeoxyglucose PET/CT using tumor-to-liver ratio - conundrum or solution?
Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001762. PubMedAbstract available
IRWIN AG Scientific support for nuclear medicine.
Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001754. PubMedAbstract available
DANG S, Shivdasani D, Pereira M, Singh N, et al Evaluation of treatment response by Hopkins criteria on18F FDG PET-CT in patients
of non-small cell lung cancer and its comparison with PERCIST response criteria.
Nucl Med Commun. 2023 Sep 4. doi: 10.1097/MNM.0000000000001756. PubMedAbstract available
ROGEAU A, Lilburn DML, Kaplar Z, Anderson C, et al Identifying and troubleshooting the pitfalls of ictal/interictal brain perfusion
SPECT studies.
Nucl Med Commun. 2023 Sep 4. doi: 10.1097/MNM.0000000000001755. PubMedAbstract available
DONG Y, Sun P, Wu H, Zhong J, et al PET/CT imaging fibroblast activation protein in initial colorectal cancer:
compared to 18F-FDG PET/CT.
Nucl Med Commun. 2023 Sep 4. doi: 10.1097/MNM.0000000000001751. PubMedAbstract available